06127.HK
JOINN Laboratories (China) Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 22.88
−1.55%Year over year
Reported trailing growth
- Revenue
- +11.4%
- EBITDA
- +128.5%
- EBIT
- +188.4%
- EPS
- +432.5%
- Free cash flow
- +140.7%
- Operating cash flow
- +246.3%
Forward estimates
Based on analyst estimates
- Revenue
- -78.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.9%
- EBITDA
- -29.2%
- EBIT
- -34.9%
- Net income
- -34.8%
- EPS
- -41.6%
- Free cash flow
- -24.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026